论文部分内容阅读
阿卡他定(alcaftadine)是Vistakon制药公司开发的一种新型组胺H1受体拮抗剂。于2010年7月获美国FDA批准上市,商品名为Lastacaft。该药为滴眼液,用于2岁以上人群过敏性结膜炎相关性眼部瘙痒的治疗。
Alcaftadine is a novel histamine H1 receptor antagonist developed by Vistakon Pharmaceuticals. In July 2010 by the US FDA approved the listing, the trade name Lastacaft. This medicine is eye drops for the treatment of allergic conjunctivitis-related eye itch in people over 2 years of age.